Unlike traditional antidiabetic and anti-obesity agents, incretins deliver comprehensive metabolic benefits, including potent glucose-lowering efficacy, sustained weight reduction, blood pressure modulation, anti-inflammatory, and antioxidant effects, as well as emerging neuroprotective properties. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.